We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Craneware Plc | LSE:CRW | London | Ordinary Share | GB00B2425G68 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-10.00 | -0.43% | 2,340.00 | 2,300.00 | 2,400.00 | 2,350.00 | 2,350.00 | 2,350.00 | 14,503 | 16:35:06 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Prepackaged Software | 189.27M | 11.7M | 0.3293 | 71.36 | 835.24M |
Date | Subject | Author | Discuss |
---|---|---|---|
30/11/2009 07:53 | Um, there was the AGM statement 10 days ago. | wjccghcc | |
29/11/2009 20:42 | Would think some news is overdue. Needs something to put some life back into the market. | leluot2 | |
01/10/2009 14:01 | From the latest results Financial Highlights * Record levels of contracted sales in the year totaling $43.2m (FY08: $25.7m), 68% up on the previous year, contributing to: * 23% increase in revenues to $23.0m (FY08: $18.7m) * 51% increase in future revenues under contract to $60.1m (FY08:$39.9m) * Profit before share based payments, depreciation and amortisation increased 29% to $5.8m (FY08: $4.5m) * Profit before taxation increased by 40% to $5.9m (FY08: $4.2m) * Cash position increased 24% to $26.1m (FY08 $21.1m) * Basic EPS increased to $0.18 (FY08: $0.14) and diluted to $0.17 (FY08: $0.13) * Final dividend proposed of 2.9p (4.77 cents) per share giving a total dividend for the year of 4.7p (7.43 cents) per share (FY08: 3.1p (4.96 cents) per share) Operational Highlights * New products lines contributed $10.1m (23%) to total contracted sales during the year * Extended market reach through partnership deals with Premier, Amerinet and Perot * Signed significant reseller agreement with McKesson Corporation post year-end * Accelerated investment in sales and marketing activities * Proposed US Healthcare reforms trend towards increased regulation and new market opportunities Keith Neilson, CEO of Craneware commented, "The US healthcare system is currently undergoing an unprecedented level of change and public scrutiny. This, combined with the global economic downturn means healthcare organisations are experiencing extraordinary levels of fiscal and legislative pressure. Craneware continues to invest in the development and deployment of software to help manage these pressures and we believe that our market leading position and reputation within the industry, combined with our strong business fundamentals, leaves us well positioned to serve this growing market demand." | pelleeds1980 | |
25/9/2009 06:56 | "This contract with one of the leading healthcare organisations in the US, won following a competitive tendering process, underlines our market-leading position and further endorses the quality of our software and customer support. Additionally, the long-term nature of the contract adds to our significant amount of future revenue under contract, giving us a high-level of confidence in the ongoing growth of Craneware." Continues to make great progress! Maybe some acquisition news next. | leluot | |
21/9/2009 07:35 | Altom - You are probably right. He just needed the readies. He had 145,000 shares and sold 10,000 of them at about £3 each. | barnesian | |
20/9/2009 16:50 | The Director who sold - how many does he have left? £30,000 does not go far these days. Could be a daughter's wedding, new boat, Harley Davison, enlargement to house, wife or girl-friend, whatever ? | altom | |
18/9/2009 15:09 | Yes - that's good news and bad news. Good that the price didn't crack. Bad that a director is selling. I assume it isn't because of any bad news to come but just an opportunity for him to take some profit at a high price. Who knows? We'll see. | barnesian | |
18/9/2009 10:56 | I see one Director sold 10,000 shares yesterday and today! Must have been the only one selling then - probably needed some pocket money!!! Price steady despite this large sell - so Barnesian - it can be done without doing any harm!! Expect some positive news soon - IMO | leluot | |
16/9/2009 13:58 | Fair comment Barnesian but I think there could well be further buying interest in the near future. Even after a few sells today the share price continued up. Strange a Scottish based company selling exclusively to the US! I think we could get a few pleasant surprises during the next six months so a temporary pull back would not worry me - although I dont think it will happen. There should be more interest in this company. As you said it is a cracking good company with a splendid track record! I also see Techinvest included CRW in its Second Half Best Buys. Dont normally follow recommendations from magazines but Techinvest is an excellent judge of young and promising tech companies - good to have their interest and support! | leluot | |
16/9/2009 13:20 | I think this is a cracking good company. It is tightly focused on the US healthcare market. It has very high margins. It is growing at a consistent 25% pa. It has excellent visibility of revenue and a pipeline of new products. It is sitting on a cash mountain of more than one year's revenue. It should have a very high rating and it does - a price today of 280p on eps of 10.3p is a P/E rating of 27 times. That is an extraordinarily high rating for an AIM company. It may go even higher based on thin trading by small traders following the share up. I'd be tempted to take some profit at this stage My fear is that if and when the small buying dries up (no share goes up for ever)or someone tries to take profit on a largish stake then any fall could be just as dramatic and overshoot on the downside. It isn't a concern or criticism of the company. I think it is first class. It is just an observation, for what it's worth, on the latest run up of the share price and its fragility. But make up your own mind. I don't want to pour cold water on the party. | barnesian | |
16/9/2009 13:02 | I dont know this share well but guess there are not many shares available- market makers may well be short. The Obama stimulus programme should give a very favourable kick to the bottomline here and I believe there is considerable scope for a continued re-rating. Fingers crossed - recent outlook statement also looked very confident. I certainly wouldnt be selling!! | leluot | |
16/9/2009 12:55 | Yup. I added on the results at 240p. The Mckesson agreement is likely to provide a large boost to their market share. | wjccghcc | |
16/9/2009 12:43 | Why would you want to get out of this share? The future looks extremely bright for US Healthcare. This could be the start of a considerable re-rating. What are you fears Barnesian? | leluot | |
16/9/2009 09:05 | Up again on very thin volume - tiny trades. Because the rally is built on such a small volume, it must surely be fragile and vulnerable to any substantial sale? How can one get out of this share if you have a decent holding? | barnesian | |
08/9/2009 10:51 | Hold recommendation from Growth Company Investor | investinggarden | |
19/4/2009 20:27 | keeps getting positive write-ups in the scottish media. see they completely ignored the stock market slump of last 12 months | brando69 | |
14/1/2009 10:41 | not Techinvest. One of my sons who had had more than a few beers !! | altom | |
13/1/2009 07:19 | Hot tip from where? Was it Techinvest? Great RNS this morning. Might buy a few myself! | ammons | |
06/1/2009 11:52 | I bought this share after a few beers and a hot tip. Very scientific! It is now my best performing share. Does anyone know anything about it? Any news due soon? | altom |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions